Stifel Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $75.2M | Sell |
1,760,990
-217,021
| -11% | -$11.8M | 0.06% | 297 |
|
|
2026
Q1 | $124M | Sell |
1,978,011
-136,486
| -6% | -$10.9M | 0.11% | 198 |
|
|
2025
Q4 | $202M | Sell |
2,114,497
-65,583
| -3% | -$6.43M | 0.18% | 138 |
|
|
2025
Q3 | $213M | Buy |
2,180,080
+126,799
| +6% | +$13.1M | 0.19% | 126 |
|
|
2025
Q2 | $221M | Buy |
2,053,281
+65,896
| +3% | +$6.67M | 0.21% | 109 |
|
|
2025
Q1 | $200M | Sell |
1,987,385
-15,813
| -0.8% | -$1.59M | 0.21% | 105 |
|
|
2024
Q4 | $179M | Sell |
2,003,198
-5,083
| -0.3% | -$447K | 0.19% | 124 |
|
|
2024
Q3 | $168M | Buy |
2,008,281
+12,040
| +0.6% | +$949K | 0.18% | 131 |
|
|
2024
Q2 | $154M | Sell |
1,996,241
-125,425
| -6% | -$9.18M | 0.17% | 129 |
|
|
2024
Q1 | $145M | Buy |
2,121,666
+28,108
| +1% | +$1.81M | 0.17% | 141 |
|
|
2023
Q4 | $121M | Buy |
2,093,558
+62,565
| +3% | +$3.34M | 0.15% | 152 |
|
|
2023
Q3 | $107M | Buy |
2,030,993
+243,878
| +14% | +$12.8M | 0.15% | 152 |
|
|
2023
Q2 | $96.7M | Sell |
1,787,115
-6,304
| -0.4% | -$329K | 0.13% | 171 |
|
|
2023
Q1 | $89.7M | Buy |
1,793,419
+53,866
| +3% | +$2.54M | 0.13% | 171 |
|
|
2022
Q4 | $80.5M | Buy |
1,739,553
+135,009
| +8% | +$5.85M | 0.12% | 186 |
|
|
2022
Q3 | $62.1M | Buy |
1,604,544
+79,205
| +5% | +$3.18M | 0.1% | 206 |
|
|
2022
Q2 | $56.8M | Buy |
1,525,339
+36,512
| +2% | +$1.49M | 0.09% | 228 |
|
|
2022
Q1 | $65.9M | Buy |
1,488,827
+26,663
| +2% | +$1.16M | 0.09% | 217 |
|
|
2021
Q4 | $62.1M | Buy |
1,462,164
+44,336
| +3% | +$1.86M | 0.08% | 228 |
|
|
2021
Q3 | $61.5M | Buy |
1,417,828
+39,074
| +3% | +$1.73M | 0.09% | 212 |
|
|
2021
Q2 | $59M | Buy |
1,378,754
+24,352
| +2% | +$1.02M | 0.09% | 218 |
|
|
2021
Q1 | $52.3M | Sell |
1,354,402
-496,228
| -27% | -$18.8M | 0.09% | 224 |
|
|
2020
Q4 | $66.5M | Sell |
1,850,630
-257,812
| -12% | -$9.29M | 0.12% | 177 |
|
|
2020
Q3 | $80.6M | Buy |
2,108,442
+47,284
| +2% | +$1.82M | 0.17% | 135 |
|
|
2020
Q2 | $72.4M | Buy |
2,061,158
+165,290
| +9% | +$5.95M | 0.17% | 140 |
|
|
2020
Q1 | $61.8M | Sell |
1,895,868
-137,638
| -7% | -$5.38M | 0.17% | 141 |
|
|
2019
Q4 | $92M | Buy |
2,033,506
+224,909
| +12% | +$9.41M | 0.19% | 129 |
|
|
2019
Q3 | $73.6M | Sell |
1,808,597
-20,248
| -1% | -$858K | 0.19% | 141 |
|
|
2019
Q2 | $78.6M | Buy |
1,828,845
+148,903
| +9% | +$5.73M | 0.2% | 130 |
|
|
2019
Q1 | $64.5M | Sell |
1,679,942
-36,730
| -2% | -$1.4M | 0.18% | 145 |
|
|
2018
Q4 | $60.7M | Buy |
1,716,672
+102,486
| +6% | +$3.72M | 0.2% | 134 |
|
|
2018
Q3 | $62.2M | Buy |
1,614,186
+20,202
| +1% | +$706K | 0.18% | 137 |
|
|
2018
Q2 | $52.1M | Sell |
1,593,984
-34,640
| -2% | -$1.04M | 0.16% | 146 |
|
|
2018
Q1 | $44.5M | Buy |
1,628,624
+6,715
| +0.4% | +$183K | 0.14% | 166 |
|
|
2017
Q4 | $40.2M | Buy |
1,621,909
+69,588
| +4% | +$1.92M | 0.13% | 176 |
|
|
2017
Q3 | $45.3M | Buy |
1,552,321
+233,141
| +18% | +$6.44M | 0.16% | 154 |
|
|
2017
Q2 | $36.6M | Buy |
1,319,180
+43,891
| +3% | +$1.16M | 0.14% | 169 |
|
|
2017
Q1 | $31.7M | Buy |
1,275,289
+334,255
| +36% | +$8.13M | 0.12% | 187 |
|
|
2016
Q4 | $20.3M | Buy |
941,034
+103,486
| +12% | +$2.26M | 0.09% | 247 |
|
|
2016
Q3 | $19.9M | Buy |
837,548
+483,212
| +136% | +$11.5M | 0.09% | 240 |
|
|
2016
Q2 | $8.28M | Sell |
354,336
-211,891
| -37% | -$4.58M | 0.04% | 419 |
|
|
2016
Q1 | $10.7M | Sell |
566,227
-117,615
| -17% | -$2.07M | 0.06% | 316 |
|
|
2015
Q4 | $12.6M | Buy |
683,842
+128,555
| +23% | +$2.3M | 0.07% | 305 |
|
|
2015
Q3 | $9.11M | Buy |
555,287
+13,185
| +2% | +$225K | 0.05% | 360 |
|
|
2015
Q2 | $9.59M | Buy |
542,102
+1,235
| +0.2% | +$22.1K | 0.05% | 377 |
|
|
2015
Q1 | $9.6M | Buy |
540,867
+34,241
| +7% | +$541K | 0.05% | 412 |
|
|
2014
Q4 | $6.71M | Sell |
506,626
-234,883
| -32% | -$3M | 0.04% | 508 |
|
|
2014
Q3 | $8.76M | Sell |
741,509
-1,041
| -0.1% | -$13.1K | 0.08% | 305 |
|
|
2014
Q2 | $9.48M | Buy |
742,550
+302,744
| +69% | +$3.94M | 0.09% | 293 |
|
|
2014
Q1 | $5.95M | Buy |
+439,806
| New | +$5.77M | 0.06% | 392 |
|
Other funds holding BSX
Stifel Financial's BSX Position: Q2 2026 in Review
Stifel Financial reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $11.8M and leaving 1,760,990 shares worth $75.2M. The position accounts for 0.06% of the portfolio, ranked #297.
Stifel Financial first reported a position in BSX in Q1 2014 and has held it in 50 quarters since. The position peaked at $221M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Stifel Financial held 1,760,990 shares of Boston Scientific worth $75.2M as of Q2 2026.
- Stifel Financial sold 217,021 Boston Scientific shares in Q2 2026, an estimated $11.8M.
- Boston Scientific made up 0.06% of Stifel Financial's portfolio in Q2 2026, its #297 holding.
- Stifel Financial first reported a position in Boston Scientific in Q1 2014 and has held it in 50 quarters since.
- Stifel Financial's Boston Scientific position peaked at $221M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.